Signaling pathways
-
BA2864 AlofanibSummary: Alofanib (RPT835) is a potent and selective variant inhibitor of fibroblast growth factor receptor 2. - BA2865 KY-05009Summary: KY-05009 is an ATP-competitive inhibitor.
- BA2866 DihydrokaempferolSummary: Could be a good candidate for new anti-arthritic drugs.
- BA2867 PrinomastatSummary: Prinomastat (AG3340) is a broad-spectrum, potent, orally active metalloproteinase inhibitor.
- BA2868 TZ9Summary: TZ9 is a selective inhibitor.
- BA2869 VII-31Summary: VII-31 is a NEDDylation pathway activator that inhibits tumors in vitro and in vivo.
- BA2870 BLM-IN-1Summary: BLM-IN-1 is a potent inhibitor of Bloom syndrome proteins.
- BA2871 Thalidomide-5-OHSummary: Thalidomide-5-OH is a Thalidomide-based, protein-recruitable ligand.
- BA2872 PTC-028Summary: PTC-028 is an orally effective inhibitor of stem cell factor for the study of ovarian cancer.
- BA2873 LuxeptinibSummary: Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent inhibitor.